Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VALIANT LABORATORIES LTD. Gains 12%; BSE HEALTHCARE Index Down 0.3%
Thu, 11 Jul 15:28

VALIANT LABORATORIES LTD. Gains 12%; BSE HEALTHCARE Index Down 0.3%Image source: Kameleon007 /www.istockphoto.com

VALIANT LABORATORIES LTD. share price has zoomed 12% and is presently trading at Rs 152.6.

Meanwhile, the BSE HEALTHCARE index is at 38,446.1 (down 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 4.6%) and GLAND PHARMA (up 3.6%).

AJANTA PHARMA (down 1.7%) and Cadila Healthcare (down 1.5%) are among the top losers today.

Over the last one year, VALIANT LABORATORIES LTD. has moved up from Rs 0.0 to Rs 152.6, registering a gain of Rs 152.6 .

On the other hand, the BSE HEALTHCARE index has moved up from 25,922.2 to 38,446.1, registering a gain of 48.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 108.3%), Lupin (up 101.8%) and Cadila Healthcare (up 100.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,909.2 .

The top losers among the BSE Sensex today are Bajaj Finance (down 1.5%) and M&M (down 1.3%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 24,344.7 (up 0.1%). ONGC and Coal India are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,344.2 to 79,909.2, registering a gain of 14,565.0 points (up 22.3%).

VALIANT LABORATORIES LTD. Financial Update...

VALIANT LABORATORIES LTD. net profit fell {profitpercent} YoY to Rs -12 million for the quarter ended March 2024, compared to a profit of Rs {profitnumberprev} million a year ago. Net sales declined {salespercent} to Rs 306 million during the period as against Rs {salesnumberprev} million in {quarterprev}.

For the year ended March 2023, VALIANT LABORATORIES LTD. reported 5.5% increase in net profit to Rs 290 million compared to net profit of Rs 275 million during FY22. Revenue of the company grew 14.5% to Rs 3,339 million during FY23.


Equitymaster requests your view! Post a comment on "VALIANT LABORATORIES LTD. Gains 12%; BSE HEALTHCARE Index Down 0.3%". Click here!